Table 4.
Drug samples (in testable form for spectrometry analysis) failing quality testsa
| Sampling | Total Minilab failures |
Total visual inspection failures |
Total Raman spectrometry failures |
|---|---|---|---|
| Lagos 2007 | (7/20) 35% | (3/20) 15% | (7/20) 35% |
| Lagos 2008 | (18/112) 16.1% | (11/112) 9.8% | (28/112) 25% |
| Lagos 2010 | (9/87) 10.3% | (6/87) 6.9% | (16/87) 18.4% |
| Lagos Total | (34/219) 15.5% | (20/219) 9.1% | (51/219) 23.3% |
| Accra 2007 | (12/34) 35.3% | (4/34) 11.8% | (14/34) 41.2% |
| Accra 2010 | (9/47) 19.1% | (5/47) 10.6% | (14/47) 29.8% |
| Accra Total | (21/81) 25.9% | (9/81) 11.1% | (28/81) 34.6% |
| TOTAL | (55/300) 18.3% | (29/300) 9.7% | (79/300) 26.3% |
a. Percentages are supported by (total that failed testing/total samples tested)